chr10-122488726-C-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_002775.5(HTRA1):​c.473-176C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0463 in 152,290 control chromosomes in the GnomAD database, including 235 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.046 ( 235 hom., cov: 32)

Consequence

HTRA1
NM_002775.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.70

Publications

2 publications found
Variant links:
Genes affected
HTRA1 (HGNC:9476): (HtrA serine peptidase 1) This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]
HTRA1 Gene-Disease associations (from GenCC):
  • CARASIL syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • genetic cerebral small vessel disease
    Inheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
  • HTRA1-related autosomal dominant cerebral small vessel disease
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 10-122488726-C-G is Benign according to our data. Variant chr10-122488726-C-G is described in ClinVar as Benign. ClinVar VariationId is 1263788.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0632 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTRA1NM_002775.5 linkc.473-176C>G intron_variant Intron 1 of 8 ENST00000368984.8 NP_002766.1 Q92743

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTRA1ENST00000368984.8 linkc.473-176C>G intron_variant Intron 1 of 8 1 NM_002775.5 ENSP00000357980.3 Q92743
HTRA1ENST00000648167.1 linkc.155-176C>G intron_variant Intron 1 of 8 ENSP00000498033.1 A0A3B3IU24

Frequencies

GnomAD3 genomes
AF:
0.0464
AC:
7057
AN:
152172
Hom.:
234
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0168
Gnomad AMI
AF:
0.0351
Gnomad AMR
AF:
0.0472
Gnomad ASJ
AF:
0.0677
Gnomad EAS
AF:
0.0672
Gnomad SAS
AF:
0.0178
Gnomad FIN
AF:
0.0364
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0648
Gnomad OTH
AF:
0.0621
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0463
AC:
7056
AN:
152290
Hom.:
235
Cov.:
32
AF XY:
0.0440
AC XY:
3280
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0168
AC:
699
AN:
41572
American (AMR)
AF:
0.0471
AC:
721
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0677
AC:
235
AN:
3470
East Asian (EAS)
AF:
0.0672
AC:
348
AN:
5178
South Asian (SAS)
AF:
0.0174
AC:
84
AN:
4822
European-Finnish (FIN)
AF:
0.0364
AC:
386
AN:
10612
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0648
AC:
4406
AN:
68012
Other (OTH)
AF:
0.0614
AC:
130
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
348
696
1043
1391
1739
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0224
Hom.:
12
Bravo
AF:
0.0478
Asia WGS
AF:
0.0350
AC:
123
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.050
DANN
Benign
0.46
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12267142; hg19: chr10-124248242; API